This is a prospective data collection study of patients with advanced solid...
Status
Completed
Location
Natera
Start Date
2021-05-28
Trial ID
NCT04761783
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
PHASE3
The primary objective of this study is to evaluate the effectiveness of zan...